Measurements of deposition, lung surface area and lung fluid for simulation of inhaled compounds

Frontiers in Pharmacology

Volumn 7, Issue JUN, 2016, Pages

  Fröhlich, Eleonore ^a   Mercuri, Annalisa ^b   Wu, Shengqian ^b   Salar Behzadi, Sharareh ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH   (Austria)

Author keywords

Deposition; In silico modeling; Inhalation; Lung lining fluid; Lung surface area

Indexed keywords

MUCIN; TUBERCULOSTATIC AGENT;

AEROSOL; BREATHING MECHANICS; BRONCHOALVEOLAR LAVAGE FLUID; COMPUTATIONAL FLUID DYNAMICS; DRUG ABSORPTION; DRUG TISSUE LEVEL; EPITHELIAL LINING FLUID; HUMAN; INHALATION; LUNG; LUNG FLUID; LUNG MINUTE VOLUME; LUNG MODEL; LUNG SURFACE AREA; NONHUMAN; PROTEIN CONTENT; RESPIRATORY EPITHELIUM; REVIEW; SIMULATION; STOCHASTIC MODEL; SURFACE AREA; TISSUE DISTRIBUTION; VOLUME OF DISTRIBUTION;

EID: 84977640442     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2016.00181     Document Type: Review

References (103)

1. Ahmed, A., Prime, D., Burnell, P. K., and Hogger, P. (2012). Development of an in vitro model to assess deposition of aerosol particles in a representative replica of the rat's respiratory tract. J. Aerosol Med. Pulm. Drug Deliv. 25, 169-178. doi: 10.1089/jamp.2011.0902
2. Arms, A., and Travis, C. (1988). Reference Physiological Parameters in Pharmacokinetic Modeling. Washington, DC: Office of Health and Environmental Assessment, Office of Research and Development. EPA/600/6-88/004.
3. Asgharian, B., Hofmann, W., and Bergmann, R. (2001). Particle deposition in a multiple-path model of the human lung. Aerosol Sci. Technol. 34, 332-339. doi: 10.1080/02786820119122
4. Baldwin, D. R., Wise, R., Andrews, J. M., and Honeybourne, D. (1991). Microlavage: a technique for determining the volume of epithelial lining fluid. Thorax 46, 658-662. doi: 10.1136/thx.46.9.658
5. Biddiscombe, M. F., Meah, S. N., Underwood, S. R., and Usmani, O. S. (2011). Comparing lung regions of interest in gamma scintigraphy for assessing inhaled therapeutic aerosol deposition. J. Aerosol Med. Pulm. Drug Deliv. 24, 165-173. doi: 10.1089/jamp.2010.0845
6. Bide, R., Armour, S., and Yee, E. (1997). Estimation of Human Toxicity from Animal Inhalation Toxicity Data: 1. Minute Volume-Body Weight Relationships between Animals and Man. SUFFIELD REPORT 673 19980129 033.
7. Bocci, V. (2011). "The potential toxicity of ozone: side effects and contraindications of ozone therapy, "in Ozone: A New Medical Drug (Dordrecht: Springer), 75-84.
8. Bohr, A., Ruge, C., and Beck-Broichsitter, M. (2014). "Preparation of nanoscale pulmonary drug delivery formulations by spray drying, "in Nanomaterial: Impacts on Cell Biology and Medicine, eds D. G. Capco and Y. Chen (Dordrecht: Springer), 183-206.
9. Bradley, M. O., Bhuyan, B., Francis, M. C., Langenbach, R., Peterson, A., and Huberman, E. (1981). Mutagenesis by chemical agents in V79 chinese hamster cells: a review and analysis of the literature. A report of the Gene-Tox Program. Mutat. Res. 87, 81-142. doi: 10.1016/0165-1110(81)90029-4
10. Breatnach, E., Abbott, G. C., and Fraser, R. G. (1984). Dimensions of the normal human trachea. Am. J. Roentgenol. 142, 903-906. doi: 10.2214/ajr.142.5.903
11. Busher, J. (1990). "Serum albumin and globulin, "in Clinical Methods: The History, Physical, and Laboratory Examinations, eds H. Walker, W. Hall, and J. Hurst (Boston, MA: Butterworths).
12. Button, B., Cai, L. H., Ehre, C., Kesimer, M., Hill, D. B., Sheehan, J. K., et al. (2012). A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science 337, 937-941. doi: 10.1126/science.1223012
13. Chastre, J., Brun, P., Fourtillan, J. B., Soler, P., Basset, G., Manuel, C., et al. (1987). Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic. Antimicrob. Agents Chemother. 31, 1312-1316. doi: 10.1128/AAC.31.9.1312
14. Chen, R., and Chen, C. (2016). "Exposure scenarios in the workplace and risk assessment of carbon nanomaterials, "in Biomedical Applications ad Toxicology of Carbon Nanomaterials, eds C. Chen and H. Wang (Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA), 515-534. doi: 10.1002/9783527692866.ch16
15. Choong, C. K., Macklem, P. T., Pierce, J. A., Lefrak, S. S., Woods, J. C., Conradi, M. S., et al. (2007). Transpleural ventilation of explanted human lungs. Thorax 62, 623-630. doi: 10.1136/thx.2005.053256
16. Dillard, R., Eastman, H., and Fordtran, J. (1965). Volume-flow relationship during the transport of fluid through the human small intestine. Gastroenterology 49, 58-66.
17. Dunnill, M. S. (1962). Quantitative methods in the study of pulmonary pathology. Thorax 17, 320-328. doi: 10.1136/thx.17.4.320
18. Egan, M. J., and Nixon, W. (1985). A model of aerosol deposition in the lung for use in inhalation dose assessments. Radiat. Protect. Dosimetry 11, 5-17.
19. EPA United States Environmental Protection Agency (2004) Air Quality Criteria for Particulate Matter Volume II. Washington, DC: Environmental Protection Agency.
20. Fahy, J. V., and Dickey, B. F. (2010). Airway mucus function and dysfunction. N. Engl. J. Med. 363, 2233-2247. doi: 10.1056/NEJMra0910061
21. Fehrenbach, H. (2001). Alveolar epithelial type II cell: defender of the alveolus revisited. Respir. Res. 2, 33-46. doi: 10.1186/rr36
22. Feuerstein, T., and Zeitlinger, M. (2011). "Microdialysis in lung tissue: monitoring of exogenous and endogenous compounds, "in Applications of Microdialysis in Pharmaceutical Science, ed T. Tsai (Hoboken. NJ: John Wiley & Sons Inc.), 255-274.
23. Fick, R. B. Jr., Naegel, G. P., Squier, S. U., Wood, R. E., Gee, J. B., and Reynolds, H. Y. (1984). Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis. J. Clin. Invest. 74, 236-248. doi: 10.1172/JCI111407
24. Filippenko, L. N. (1978). Light and electron microscopic study of rat lung brush alveolocytes. Biull. Eksp. Biol. Med. 86, 592-596.
25. Fröhlich, E., Pieber, T. R., and Roblegg, E. (2012). "What is the role of in-vitro models in the estimation of the health risk caused by nanoparticle exposure?, "in Risk Assessment and Management, ed Z. Zhang (Cheyenne, WY: Publishing Services LLC), 258-276.
26. Fröhlich, E., and Salar-Behzadi, S. (2014). Toxicological assessment of inhaled nanoparticles: role of in vivo, ex vivo, in vitro, and in silico studies. Int. J. Mol. Sci. 15, 4795-4822. doi: 10.3390/ijms15034795
27. Fronius, M., Clauss, W. G., and Althaus, M. (2012). Why do we have to move fluid to be able to breathe? Front. Physiol. 3:146. doi: 10.3389/fphys.2012.00146
28. Gaohua, L., Wedagedera, J., Small, B. G., Almond, L., Romero, K., Hermann, D., et al. (2015). Development of a multicompartment permeability-limited lung PBPK model and its application in predicting pulmonary pharmacokinetics of antituberculosis drugs. CPT Pharmacometrics Syst. Pharmacol. 4, 605-613. doi: 10.1002/psp4.12034
29. Gehr, P., Bachofen, M., and Weibel, E. R. (1978). The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. Respir. Physiol. 32, 121-140. doi: 10.1016/0034-5687(78)90104-4
30. Gregoratto, D., Bailey, M. R., and Marsh, J. W. (2011). Particle clearance in the alveolar-interstitial region of the human lungs: model validation. Radiat. Protect. Dosimetry 144, 353-356. doi: 10.1093/rpd/ncq314
31. Guha, S., Hariharan, P., and Myers, M. (2014). Enhancement of ICRP's lung deposition model for pathogenic bioaerosols. Aerosol Sci. Technol. 48, 1226-1235. doi: 10.1080/02786826.2014.975334
32. Hasleton, P. S. (1972). The internal surface area of the adult human lung. J. Anat. 112, 391-400.
33. Helander, H. F., and Fandriks, L. (2014). Surface area of the digestive tract-revisited. Scand. J. Gastroenterol. 49, 681-689. doi: 10.3109/00365521.2014.898326
34. Hickey, A., and Swift, D. (2011). "Measurement of pharmaceutical and diagnostic inhalation aerosols, "in Aerosol Measurement Principles, Techniques, and Applications, eds P. Kulkarni, P. Baron, and K. Willeke (Hoboken, NJ: Wiley & Sons, Inc.).
35. Hiemstra, P. (2010). "Host defense against infection in the airways, "in Respiratory Infections, ed S. Sethi (Boca Raton, FL: CRC Press), 17-28.
36. Hoad, C. L., Marciani, L., Foley, S., Totman, J. J., Wright, J., Bush, D., et al. (2007). Non-invasive quantification of small bowel water content by MRI: a validation study. Phys. Med. Biol. 52, 6909-6922. doi: 10.1088/0031-9155/52/23/009
37. Hoffmann, G., Cracknell, S., Damiano, J., Macri, N., and Moore, S. (2014). "Inhalation toxicology, "in Handbook of Toxicology, eds M. Derelanko and C. Auletta (Boca Raton, FL: CRC Press), 233-302.
38. Hofmann, W. (2011). Modelling inhaled particle deposition in the human lung-A review. J. Aerosol Sci. 42, 693-724. doi: 10.1016/j.jaerosci.2011.05.007
39. Hofmann, W., and Asgharian, B. (2003). The effect of lung structure on mucociliary clearance and particle retention in human and rat lungs. Toxicol. Sci. 73, 448-456. doi: 10.1093/toxsci/kfg075
40. Hofmann, W., and Koblinger, L. (1990). Monte Carlo modeling of aerosol deposition in human lungs. Part II: deposition fractions and their sensitivity to parameter variations. J. Aerosol Sci. 21, 675-688. doi: 10.1016/0021-8502(90)90122-E
41. Hofmann, W., and Koblinger, L. (1992). Monte-Carlo modeling of aerosol deposition in human lungs. Part III. Comparison with experimental data. J. Aerosol Med. 23, 51-63. doi: 10.1016/0021-8502(92)90317-O
42. Hofmann, W., Martonen, T. B., and Graham, R. C. (1989). Predicted deposition of non hygroscopic aerosols in the human lung as a function of subject age. J. Aerosol Med. 2, 49-68. doi: 10.1089/jam.1989.2.49
43. Hofmann, W., and Sturm, R. (2004). Stochastic model of particle clearance in human bronchial airways. J. Aerosol Med. 17, 73-89. doi: 10.1089/089426804322994488
44. Holbert, J. M., and Strollo, D. C. (1995). Imaging of the normal trachea. J. Thoracic Imaging 10, 171-179. doi: 10.1097/00005382-199522000-00003
45. Holter, J. F., Weiland, J. E., Pacht, E. R., Gadek, J. E., and Davis, W. B. (1986). Protein permeability in the adult respiratory distress syndrome. Loss of size selectivity of the alveolar epithelium. J. Clin. Invest. 78, 1513-1522. doi: 10.1172/JCI112743
46. ICRP (1994). Human respiratory tract model for radiological protection. Ann. ICRP 24, 1-3. doi: 10.1016/0146-6453(94)90004-3
47. Jarabek, A. M., Asgharian, B., and Miller, F. J. (2005). Dosimetric adjustments for interspecies extrapolation of inhaled poorly soluble particles (PSP). Inhal. Toxicol. 17, 317-334. doi: 10.1080/08958370590929394
48. Ji, J., and Yu, J. (2012). Estimation of human equivalent exposure from rat inhalation toxicity study of silver nanoparticles using multi-path particle dosimetry model. Toxicol. Res. 1, 206-210. doi: 10.1039/c2tx20029e
49. Jones, H. M., Gardner, I. B., and Watson, K. J. (2009). Modelling and PBPK simulation in drug discovery. Aaps J. 11, 155-166. doi: 10.1208/s12248-009-9088-1
50. Kane, D. B., Asgharian, B., Price, O. T., Rostami, A., and Oldham, M. J. (2010). Effect of smoking parameters on the particle size distribution and predicted airway deposition of mainstream cigarette smoke. Inhal. Toxicol. 22, 199-209. doi: 10.3109/08958370903161224
51. Kesimer, M., Ehre, C., Burns, K. A., Davis, C. W., Sheehan, J. K., and Pickles, R. J. (2013). Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways. Mucosal Immunol. 6, 379-392. doi: 10.1038/mi.2012.81
52. Klech, H., and Pohl, W. (1989). Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group. Eur. Respir. J. 2, 561-585.
53. Koblinger, L., and Hofmann, W. (1990). Monte Carlo modeling of aerosol deposition in human lungs. PartI: simulation of particle transport in a stochastic lung structure. J. Aerosol Sci. 21, 661-674. doi: 10.1016/0021-8502(90)90121-D
54. Kobzik, L. (2007). "Lung immune defenses against environmental agents, "in Environmental and Occupational Medicine, eds W. Rom and S. Markowitz (Philadelphia, PA: Lippincott Williams & Wilkins), 187-199.
55. Kostewicz, E. S., Aarons, L., Bergstrand, M., Bolger, M. B., Galetin, A., Hatley, O., et al. (2014). PBPK models for the prediction of in vivo performance of oral dosage forms. Eur. J. Pharm. Sci. 57, 300-321. doi: 10.1016/j.ejps.2013.09.008
56. Kuempel, E. D., Tran, C. L., Castranova, V., and Bailer, A. J. (2006). Lung dosimetry and risk assessment of nanoparticles: evaluating and extending current models in rats and humans. Inhal. Toxicol. 18, 717-724. doi: 10.1080/08958370600747887
57. Lamer, C., de Beco, V., Soler, P., Calvat, S., Fagon, J. Y., Dombret, M. C., et al. (1993). Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients. Antimicrob. Agents Chemother. 37, 281-286. doi: 10.1128/AAC.37.2.281
58. Lenfant, C. (2000). "Discovery of endogenous surfactant and overview of its metabolism and actions, "in Lung Surfactants, Basic Science and Clinical Applications, ed R. Notter (New York, NY: Marcel Dekker, Inc.), 119-150.
59. Lipscomb, J., Haddad, S., Poet, T., and Krishnan, K. (2012). Physiologically-based pharmacokinetic (PBPK) models in toxicity testing and risk assessment. Adv. Exp. Med. Biol. 745, 76-95. doi: 10.1007/978-1-4614-3055-1_6
60. Longest, P. W., and Holbrook, L. D. (2012). In silico models of aerosol delivery to the respiratory tract-Development and applications. Adv. Drug Deliv. Rev. 64, 296-311. doi: 10.1016/j.addr.2011.05.009
61. Longest, P. W., Kleinstreuer, C., and Buchanan, J. R. (2004). Efficient computation of microparticle dynamics including wall effects. Comput. Fluids 33, 577-601. doi: 10.1016/j.compfluid.2003.06.002
62. Majid, H., Hofmann, W., and Winkler-Heil, R. (2012). Comparison of stochastic lung deposition fractions with experimental data. Ann. Occup. Hyg. 56, 278-291. doi: 10.1093/annhyg/mer100
63. Malhotra, A. (2007). Low-tidal-volume ventilation in the acute respiratory distress syndrome. N. Engl. J. Med. 357, 1113-1120. doi: 10.1056/NEJMct074213
64. Martonen, T. B. (1993). Mathematical model for the selective deposition of inhaled pharmaceuticals. J. Pharm. Sci. 82, 1191-1199. doi: 10.1002/jps.2600821202
65. Martonen, T. B., Yang, Y., Dolovich, M., and Guan, X. (1997). Computer simulations of lung morphologies within planar gamma camera images. Nucl. Med. Commun. 18, 861-869. doi: 10.1097/00006231-199709000-00011
66. Mitsakou, C., Helmis, C., and Housiadas, C. (2005). Eulerian modelling of lung deposition with sectional representation of aerosol dynamics. Aerosol Sci. Technol. 36, 75-94. doi: 10.1016/j.jaerosci.2004.08.008
67. National Council on Radiation Protection (1997). Deposition, Retention and Dosimetry of Inhaled Radioactive Substances. Bethesda, MD: National Council on Radiation Protection and Measurements.
68. National Research Council, U. (1977). "Respiratory transport and absorption, "in Ozone and other Photochemical Oxidants, ed National Academy of Science (Washington, DC: National Research Council), 280-322.
69. Niazi, S. (ed.). (2007). "Drug delivery factors, "in Handbook of Bioequivalence Testing (Boca Raton, FL: CRC Press Taylor & Francis Group), 47-86.
70. Olsson, B., Bondesson, E., Borgström, L., Edsbäcker, S., Eirefelt, S., Ekelund, K., et al. (2011). "Pulmonary drug metabolism, clearence, and absorption, "in Controlled Pulmonary Drug Delivery, eds H. Smyth and A. Hickey (New York, NY: Springer), 21-50. doi: 10.1007/978-1-4419-9745-6_2
71. Patterson, B. (2015). Modeling Paradigms for Orally Inhaled Drugs, Inhalation. St. Paul, MN: CSC Publishing.
72. Patton, J. S., and Byron, P. R. (2007). Inhaling medicines: delivering drugs to the body through the lungs. Nat. Rev. Drug Discov. (St. Paul, MN) 6, 67-74. doi: 10.1038/nrd2153
73. Phipps, P. R., Gonda, I., Bailey, D. L., Borham, P., Bautovich, G., and Anderson, S. D. (1989). Comparisons of planar and tomographic gamma scintigraphy to measure the penetration index of inhaled aerosols. Am. Rev. Respir. Dis. 139, 1516-1523. doi: 10.1164/ajrccm/139.6.1516
74. Price, O., Asgharian, B., Miller, F., Cassee, F., and de Winter-Sorkina, R. (2002). Multiple Path Particle Dosimetry Model (MPPD v 1.0): A Model for Human and Rat Airway Particle Dosimetry, National Institute for Public Health and the Environment (RIVM). RIVA Report 650010030. Bilthoven: National Institute for Public Health and the Environment.
75. Reddy, M., Clewell, I. I. I. H, Lave, T., and Andersen, M. (2013). "Physiologically based pharmacokinetic modeling: a tool for understanding ADMET properties and extrapolating to human, "in New Insights into Toxicity and Drug Testing, ed S. Gowder (Rijeka: InTech), 197-217. doi: 10.5772/54965
76. Rennard, S. I., Basset, G., Lecossier, D., O'Donnell, K. M., Pinkston, P., Martin, P. G., et al. (1986). Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60, 532-538.
77. Rosati, J., Isaacs, K., and Martonen, T. (2004). "Modeling deposition of inhaled particles, "in Aerosols Handbook Measurement, Dosimetry, and Health Effects, eds L. Ruzer and N. Harley (Boca Raton, FL: CRC Press), 109-151. doi: 10.1201/9780203493182.ch8
78. Rubin, B., and Henke, M. (2016). "Mucus-controlling therapy, "in RAU's Respiratory Care Pharmacology, ed D. Gardenhire (St. Louis, MO: Elsevier), 148-171.
79. Ruzer, L., and Harley, N. (2013). Aerosols Handbook: Management, Dosimetry, and Health Effects. Boca Raton, FL: CRC Press.
80. Schlesinger, R. (1992). "Comparative defense capabilities of the respiratory tract, "in Treatise on Pulmonary Toxicology Comparative Biology of the Normal Lung. Comparative Biochemistry of Airway Lining Fluid, Ed. Hatch, G, ed R. Parent (Boca Raton, FL: CRC Press), 617-632.
81. Smith, D. A., Di, L., and Kerns, E. H. (2010). The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat. Rev. Drug Discov. 9, 929-939. doi: 10.1038/nrd3287
82. Stephens, R. H., Benjamin, A. R., and Walters, D. V. (1996). Volume and protein concentration of epithelial lining liquid in perfused in situ postnatal sheep lungs. J. Appl. Physiol. 80, 1911-1920.
83. Sutton, S. C. (2009). Role of physiological intestinal water in oral absorption. Aaps J. 11, 277-285. doi: 10.1208/s12248-009-9087-2
84. Tarran, R., Button, B., Picher, M., Paradiso, A. M., Ribeiro, C. M., Lazarowski, E. R., et al. (2005). Normal and cystic fibrosis airway surface liquid homeostasis. The effects of phasic shear stress and viral infections. J. Biol. Chem. 280, 35751-35759. doi: 10.1074/jbc. M505832200
85. Thurlbeck, W. M. (1967). The internal surface area of nonemphysematous lungs. Am. Rev. Respir. Dis. 95, 765-773.
86. Tyvold, S. S., Solligard, E., Lyng, O., Steinshamn, S. L., Gunnes, S., and Aadahl, P. (2007). Continuous monitoring of the bronchial epithelial lining fluid by microdialysis. Respir. Res. 8, 78. doi: 10.1186/1465-9921-8-78
87. Ulleberg, E. K., Comi, I., Holm, H., Herud, E. B., Jacobsen, M., and Vegarud, G. E. (2011). Human gastrointestinal juices intended for use in in vitro digestion models. Food digestion 2, 52-61. doi: 10.1007/s13228-011-0015-4
88. van de Waterbeemd, H., and Gifford, E. (2003). ADMET in silico modelling: towards prediction paradise? Nat. Rev. Drug Discov. 2, 192-204. doi: 10.1038/nrd1032
89. Vertzoni, M., Dressman, J., Butler, J., Hempenstall, J., and Reppas, C. (2005). Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds. Eur. J. Pharm. Biopharm. 60, 413-417. doi: 10.1016/j.ejpb.2005.03.002
90. von Hayek, H. (1960). The Human Lung. New York, NY: Hafner Publishing.
91. Walters, D. V. (2002). Lung lining liquid-the hidden depths. The 5th Nils W. Svenningsen memorial lecture. Biol. Neonate 81(Suppl. 1), 2-5. doi: 10.1159/000056764
92. Wang, J., and Urban, L. (2014). "In vitro-in silico tools to predict pharmacokinetics of poorly soluble drug compounds, "in Predictive ADMET: Integrated Approaches in Drug Discovery and Development, eds J. Wang and L. Urban (Hoboken, NJ: John Wiley & Sons), 235-262.
93. Wauthoz, N., and Amighi, K. (2015). "Formulation strategies for pulmonary delivery of poorly soluble drugs, "in Pulmonary Drug Delivery Advances and Challenges, eds A. Nokhodchi and G. Martin (Chichester: John Wiley & Sons), 87-122.
94. Weibel, E. (1980). "Design and structure of the human lung, "in Pulmonary Diseases and Disorders, ed A. Fishman (New York, NY: McGraw-Hill), 224-271.
95. Weibel, E. R. (2009). What makes a good lung? Swiss Med. Wkly 139, 375-386.
96. Wilson, J. P. (1967). Surface area of the small intestine in man. Gut 8, 618-621. doi: 10.1136/gut.8.6.618
97. Wu, S., Salar-Behzadi, S., and Fröhlich, E. (2013). Role of in-silico modeling in drug development for inhalation treatment. J. Mol. Pharm. Org. Process 1:106. doi: 10.4172/2329-9053.1000106
98. Yeh, H. C., and Schum, G. M. (1980). Models of the human lung airways and their application to inhaled particle deposition. Bull. Math. Biol. 42, 461-480. doi: 10.1007/BF02460796
99. Yu, C. (1996). "Extrapolation modeling of particle deposition and retentiona from rats to humans, "in Particle overload in the rat lung and lung cancer. Proceddings of a Conference Held at the Massachusetts Institute of Technology on March 29 and 30, 1995, eds J. Mauderly and R. McCunney (Philadelphia, PA: Taylor & Francis), 279-291.
100. Yu, J. Y., and Rosania, G. R. (2010). Cell-based multiscale computational modeling of small molecule absorption and retention in the lungs. Pharm. Res. 27, 457-467. doi: 10.1007/s11095-009-0034-9
101. Zhang, Z., and Kleinstreuer, C. (2002). Transient airflow structures and particle transport in a sequentially branching lung airway model. Phys. Fluids 14, 862-880. doi: 10.1063/1.1433495
102. Zhang, Z., Kleinstreuer, C., and Kim, C. S. (2008). Airflow and nanoparticle deposition in a 16-generation tracheobronchial airway model. Ann. Biomed. Eng. 36, 2095-2110. doi: 10.1007/s10439-008-9583-z
103. Zhang, Z., Kleinstreuer, C., and Kim, C. S. (2009). Comparison of analytical and CFD models with regard to micronparticle deposition in a human 16-generation tracheobronchial airway model. J. Aerosol Sci. 40, 16-28. doi: 10.1016/j.jaerosci.2008.08.003